Full Description
Despite advances in therapeutic strategies, the five-year survival rate for CRC patients has remained the same over time due to the fact that patients are often diagnosed in advanced metastatic stages. Each volume focuses on different novel therapeutic advances, biomarkers, and identifies therapeutic targets for treatment.